Quarterly report pursuant to Section 13 or 15(d)

Summary of Significant Accounting Policies (Tables)

v3.19.3
Summary of Significant Accounting Policies (Tables)
9 Months Ended
Sep. 30, 2019
Accounting Policies [Abstract]  
Schedule of intangible assets

    September 30,     December 31,  
    2019     2018  
Intangibles with finite lives:            
Intellectual property   $ 2,101     $ 2,101  
Website - qurr.com     380       380  
Less: accumulated amortization – intellectual property     (1,152 )     (994 )
Less: accumulated amortization – website     (346 )     (242 )
Total intangible assets, net   $ 983     $ 1,245  

Schedule of intangible assets is estimated useful lives

Years Ended December 31,   Amount  
2019 (remaining three months)   $ 87  
2020     210  
2021     210  
2022     210  
2023     210  
2024     56  
Total   $ 983  

Schedule of disaggregation of revenues
    Three months ended  
    September 30,     September 30,  
Product Type   2019     2018  
Myos Canine Muscle Formula® (1)   $ 132     $ 8  
Yolked® (2)     108       13  

White label (3)

    100       -  
Qurr® (4)     10       40  
Physician Muscle Health Formula (5)     -       5  
Total Net Revenues   $ 350     $ 66  

 

    Nine months ended  
    September 30,     September 30,  
Product Type   2019     2018  
Myos Canine Muscle Formula® (1)   $ 282     $ 11  
Yolked® (2)     229       28  

White label (3)

    100       -  
Qurr® (4)     37       153  
Physician Muscle Health Formula (5)     5       19  
Total Net Revenues   $ 653     $ 211  

  

(1) Launched in June 2018
(2) Launched in March 2018
(3) White label fortetropin blend
(4) Launched in June 2017
(5) Fortetropin blend for physicians